Zhang, L., Li, Y., Wang, D., Deng, W., Zhang, S., Wang, F. J., Fu, J., Zhang, M., Zhu, Z., Yin, S., Yin, L., Zhuang, X., Wang, W., Lin, C., Du, X., Yu, G., Liu, L., Huang, Y., Leng, S., Xu, J. (2026). Randomized, double-blind phase 3 trial of the fixed-dose combination fosrolapitant/palonosetron (HR20013) plus dexamethasone for prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.11006